Results 201 to 210 of about 386,755 (358)
Characterization of a cis-regulatory element upstream of matrix metalloproteinase-9. [PDF]
Rangaraj A +5 more
europepmc +1 more source
Upregulated TRMT6 forms aberrant hypermethylation of a specific tRNA pool and serves as a predictor of poor prognosis in TNBC. This m1A modification in tRNAs enhances translation of FTH1 and FTL, reducing the pool of bioavailable Fe2⁺. Reduced Fe2+ availability impairs RSL3‐induced lipid peroxidation and tumor progression.
Yuqing Lei +12 more
wiley +1 more source
The role and mechanisms of matrix metalloproteinase-9 in peripheral neuropathic pain. [PDF]
Jia SY +5 more
europepmc +1 more source
This study presents an intravesical delivery strategy of ferroptosis‐ and immunity‐inducing nanozyme‐loaded thermoresponsive hydrogels (FMCC@PNH) for enhanced bladder cancer therapy. Abstract Current intravesical therapies for bladder cancer after resection are limited by poor tissue penetration, off‐target effects, and insufficient efficacy.
Yongnan Jiang +11 more
wiley +1 more source
Tear matrix metalloproteinase 9 immunoassay positivity reflects the severity of conjunctivochalasis. [PDF]
Lee J, Bang SP, Lee J, Shim KY, Jun JH.
europepmc +1 more source
It has been demonstrated that, in the bone extracellular matrix (ECM), integrins and growth factor receptors (GFRs) engage in synergistic signaling to guide bone healing and regeneration. This review provides a comprehensive overview of current strategies using ECM‐derived peptides to recreate the cellular microenvironment and harness synergistic ...
Lluís Oliver‐Cervelló +2 more
wiley +1 more source
Age-Related Changes in Matrix Metalloproteinase-9 Expression in Spinal Motor Neurons of Normal Mice. [PDF]
Yamazaki J +6 more
europepmc +1 more source
The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye.
N. Lanza +3 more
semanticscholar +1 more source
This study reveals that FAP promotes thoracic aortic dissection (TAD) through a nonenzymatic mechanism involving fibroblast‐macrophage crosstalk via the FAP/PLAUR/ITGB1/FAK axis. Targeting this pathway might offer a promising therapeutic strategy for TAD.
Hongqiao Zhu +7 more
wiley +1 more source

